AKV PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
AKV PHARMA
Largest movements
- Current investments -€87,137
no longer reported in 2025 (was €87,137)
- Cash +€16,866
up €16,866 (+41.3%), from €40,795 to €57,661
mainly Current investments (+€87,137) and Net result for the year (+€25,201)
- Intangible fixed assets -€11,000
no longer reported in 2025 (was €11,000)
- Tangible fixed assets -€4,949
no longer reported in 2025 (was €4,949)
of which Furniture and vehicles: -€3,363
- Other debts -€81,524
down €81,524 (-99.9%), from €81,598 to €74
- Reserves +€25,201
up €25,201 (+152.5%), from €16,526 to €41,727
- Current portion of long-term debt -€22,765
down €22,765 (-83.2%), from €27,367 to €4,602
- Debts after one year -€4,602
no longer reported in 2025 (was €4,602)
- Accrued charges and deferred income -€2,096
no longer reported in 2025 (was €2,096)
- Depreciation -€6,178
down €6,178 (-32.9%), from €18,764 to €12,586
- Gross operating margin +€5,334
up €5,334 (+15.2%), from €35,082 to €40,416
- Financial income +€4,698
up €4,698 (+310.0%), from €1,515 to €6,214
- Financial charges -€3,387
down €3,387 (-89.9%), from €3,766 to €379
- Taxes +€2,711
up €2,711 (+53.8%), from €5,040 to €7,751
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €144,837 | €58,563 | -€86,274 | -59.6% |
| Fixed assets | 21/28 | €15,949 | - | -€15,949 | |
| Intangible fixed assets | 21 | €11,000 | - | -€11,000 | |
| Tangible fixed assets | 22/27 | €4,949 | - | -€4,949 | |
| Plant, machinery and equipment | 23 | €1,586 | - | -€1,586 | |
| Furniture and vehicles | 24 | €3,363 | - | -€3,363 | |
| Current assets | 29/58 | €128,888 | €58,563 | -€70,325 | -54.6% |
| Amounts receivable within one year | 40/41 | €215 | €702 | +€487 | +227.1% |
| Other amounts receivable | 41 | €215 | €702 | +€487 | +227.1% |
| Current investments | 50/53 | €87,137 | - | -€87,137 | |
| Cash at bank and in hand | 54/58 | €40,795 | €57,661 | +€16,866 | +41.3% |
| Deferred charges and accrued income | 490/1 | €741 | €200 | -€541 | -73.0% |
| Total equity and liabilities | 10/49 | €144,837 | €58,563 | -€86,274 | -59.6% |
| Equity | 10/15 | €27,219 | €52,420 | +€25,201 | +92.6% |
| Contributions | 10/11 | €10,693 | €10,693 | = | 0.0% |
| Reserves | 13 | €16,526 | €41,727 | +€25,201 | +152.5% |
| Distributable reserves | 133 | €16,526 | €41,727 | +€25,201 | +152.5% |
| Amounts payable | 17/49 | €117,618 | €6,144 | -€111,475 | -94.8% |
| Amounts payable after more than one year | 17 | €4,602 | - | -€4,602 | |
| Financial debts | 170/4 | €4,602 | - | -€4,602 | |
| Amounts payable within one year | 42/48 | €110,921 | €6,144 | -€104,777 | -94.5% |
| Current portion of amounts payable after more than one year | 42 | €27,367 | €4,602 | -€22,765 | -83.2% |
| Trade debts | 44 | €253 | €32 | -€222 | -87.5% |
| Suppliers | 440/4 | €253 | €32 | -€222 | -87.5% |
| Taxes, remuneration and social security | 45 | €1,702 | €1,436 | -€266 | -15.6% |
| Taxes | 450/3 | €1,702 | €1,436 | -€266 | -15.6% |
| Other amounts payable | 47/48 | €81,598 | €74 | -€81,524 | -99.9% |
| Accrued charges and deferred income | 492/3 | €2,096 | - | -€2,096 | |
| Non-recurring operating income | 76A | - | €662 | +€662 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €18,764 | €12,586 | -€6,178 | -32.9% |
| Other operating charges | 640/8 | €513 | €713 | +€200 | +39.0% |
| Gross operating margin | 9900 | €35,082 | €40,416 | +€5,334 | +15.2% |
| Operating profit (loss) | 9901 | €15,805 | €27,116 | +€11,311 | +71.6% |
| Financial income | 75/76B | €1,515 | €6,214 | +€4,698 | +310.0% |
| Recurring financial income | 75 | €1,515 | €6,214 | +€4,698 | +310.0% |
| Financial charges | 65/66B | €3,766 | €379 | -€3,387 | -89.9% |
| Recurring financial charges | 65 | €3,766 | €379 | -€3,387 | -89.9% |
| Profit (loss) for the period before taxes | 9903 | €13,555 | €32,951 | +€19,397 | +143.1% |
| Income taxes | 67/77 | €5,040 | €7,751 | +€2,711 | +53.8% |
| Profit (loss) for the period | 9904 | €8,515 | €25,201 | +€16,686 | +196.0% |
| Profit (loss) for the period to be appropriated | 9905 | €8,515 | €25,201 | +€16,686 | +196.0% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.